127 related articles for article (PubMed ID: 37766386)
1. Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease.
Zhu G; Li J; Lin X; Zhang Z; Hu T; Huo S; Li Y
J Med Chem; 2023 Oct; 66(19):13501-13515. PubMed ID: 37766386
[TBL] [Abstract][Full Text] [Related]
2. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose.
Futatsugi K; Smith AC; Tu M; Raymer B; Ahn K; Coffey SB; Dowling MS; Fernando DP; Gutierrez JA; Huard K; Jasti J; Kalgutkar AS; Knafels JD; Pandit J; Parris KD; Perez S; Pfefferkorn JA; Price DA; Ryder T; Shavnya A; Stock IA; Tsai AS; Tesz GJ; Thuma BA; Weng Y; Wisniewska HM; Xing G; Zhou J; Magee TV
J Med Chem; 2020 Nov; 63(22):13546-13560. PubMed ID: 32910646
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
Gutierrez JA; Liu W; Perez S; Xing G; Sonnenberg G; Kou K; Blatnik M; Allen R; Weng Y; Vera NB; Chidsey K; Bergman A; Somayaji V; Crowley C; Clasquin MF; Nigam A; Fulham MA; Erion DM; Ross TT; Esler WP; Magee TV; Pfefferkorn JA; Bence KK; Birnbaum MJ; Tesz GJ
Mol Metab; 2021 Jun; 48():101196. PubMed ID: 33667726
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK).
Huard K; Ahn K; Amor P; Beebe DA; Borzilleri KA; Chrunyk BA; Coffey SB; Cong Y; Conn EL; Culp JS; Dowling MS; Gorgoglione MF; Gutierrez JA; Knafels JD; Lachapelle EA; Pandit J; Parris KD; Perez S; Pfefferkorn JA; Price DA; Raymer B; Ross TT; Shavnya A; Smith AC; Subashi TA; Tesz GJ; Thuma BA; Tu M; Weaver JD; Weng Y; Withka JM; Xing G; Magee TV
J Med Chem; 2017 Sep; 60(18):7835-7849. PubMed ID: 28853885
[TBL] [Abstract][Full Text] [Related]
5. Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects.
Miller CO; Yang X; Lu K; Cao J; Herath K; Rosahl TW; Askew R; Pavlovic G; Zhou G; Li C; Akiyama TE
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E386-E393. PubMed ID: 29870677
[TBL] [Abstract][Full Text] [Related]
6. Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation.
Helsley RN; Park SH; Vekaria HJ; Sullivan PG; Conroy LR; Sun RC; Romero MDM; Herrero L; Bons J; King CD; Rose J; Meyer JG; Schilling B; Kahn CR; Softic S
J Hepatol; 2023 Jul; 79(1):25-42. PubMed ID: 36822479
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial.
Kazierad DJ; Chidsey K; Somayaji VR; Bergman AJ; Birnbaum MJ; Calle RA
Med; 2021 Jul; 2(7):800-813.e3. PubMed ID: 35590219
[TBL] [Abstract][Full Text] [Related]
8. A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes.
Park SH; Helsley RN; Noetzli L; Tu HC; Wallenius K; O'Mahony G; Boucher J; Liu J; Softic S
STAR Protoc; 2021 Sep; 2(3):100731. PubMed ID: 34409309
[TBL] [Abstract][Full Text] [Related]
9. Michaelis-like complex of mouse ketohexokinase isoform C.
Gasper WC; Gardner S; Ross A; Oppelt SA; Allen KN; Tolan DR
Acta Crystallogr D Struct Biol; 2024 Jun; 80(Pt 6):377-385. PubMed ID: 38805243
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via ketohexokinase-dependent pathway.
Marek G; Pannu V; Shanmugham P; Pancione B; Mascia D; Crosson S; Ishimoto T; Sautin YY
Diabetes; 2015 Feb; 64(2):508-18. PubMed ID: 25187370
[TBL] [Abstract][Full Text] [Related]
11. Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice.
Lanaspa MA; Andres-Hernando A; Orlicky DJ; Cicerchi C; Jang C; Li N; Milagres T; Kuwabara M; Wempe MF; Rabinowitz JD; Johnson RJ; Tolan DR
J Clin Invest; 2018 Jun; 128(6):2226-2238. PubMed ID: 29533924
[TBL] [Abstract][Full Text] [Related]
12. Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis.
Shepherd EL; Saborano R; Northall E; Matsuda K; Ogino H; Yashiro H; Pickens J; Feaver RE; Cole BK; Hoang SA; Lawson MJ; Olson M; Figler RA; Reardon JE; Nishigaki N; Wamhoff BR; Günther UL; Hirschfield G; Erion DM; Lalor PF
JHEP Rep; 2021 Apr; 3(2):100217. PubMed ID: 33490936
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase).
Bonthron DT; Brady N; Donaldson IA; Steinmann B
Hum Mol Genet; 1994 Sep; 3(9):1627-31. PubMed ID: 7833921
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity-Guided Identification of Botanical Inhibitors of Ketohexokinase.
Le MT; Lanaspa MA; Cicerchi CM; Rana J; Scholten JD; Hunter BL; Rivard CJ; Randolph RK; Johnson RJ
PLoS One; 2016; 11(6):e0157458. PubMed ID: 27322374
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
[TBL] [Abstract][Full Text] [Related]
16. Bone Growth is Influenced by Fructose in Adolescent Male Mice Lacking Ketohexokinase (KHK).
Williams EAJ; Douard V; Sugimoto K; Inui H; Devime F; Zhang X; Kishida K; Ferraris RP; Fritton JC
Calcif Tissue Int; 2020 May; 106(5):541-552. PubMed ID: 31996963
[TBL] [Abstract][Full Text] [Related]
17. Ketohexokinase-A deficiency attenuates the proliferation via reducing β-catenin in gastric cancer cells.
Ma G; Liu S; Cai F; Liang H; Deng J; Zhang R; Cai M
Exp Cell Res; 2024 May; 438(1):114038. PubMed ID: 38614422
[TBL] [Abstract][Full Text] [Related]
18. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.
Cirillo P; Gersch MS; Mu W; Scherer PM; Kim KM; Gesualdo L; Henderson GN; Johnson RJ; Sautin YY
J Am Soc Nephrol; 2009 Mar; 20(3):545-53. PubMed ID: 19158351
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of human and mouse ketohexokinase provide a structural basis for species- and isoform-selective inhibitor design.
Ebenhoch R; Bauer M; Romig H; Gottschling D; Kley JT; Heine N; Weber A; Uphues I; Nar H; Pautsch A
Acta Crystallogr D Struct Biol; 2023 Oct; 79(Pt 10):871-880. PubMed ID: 37712434
[TBL] [Abstract][Full Text] [Related]
20. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.
Lanaspa MA; Sanchez-Lozada LG; Cicerchi C; Li N; Roncal-Jimenez CA; Ishimoto T; Le M; Garcia GE; Thomas JB; Rivard CJ; Andres-Hernando A; Hunter B; Schreiner G; Rodriguez-Iturbe B; Sautin YY; Johnson RJ
PLoS One; 2012; 7(10):e47948. PubMed ID: 23112875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
